Home
>
National Drug Code (NDC)
>
SORIATANE
SORIATANE - 0145-3817-03 - (acitretin)
Drug Information of SORIATANE
| Product NDC: | 0145-3817 |
| Proprietary Name: | SORIATANE |
| Non Proprietary Name: | acitretin |
| Active Ingredient(s): | 17.5 mg/1 & nbsp; acitretin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of SORIATANE
| Product NDC: | 0145-3817 |
| Labeler Name: | Stiefel Laboratories Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019821 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100104 |
Package Information of SORIATANE
| Package NDC: | 0145-3817-03 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (0145-3817-03) |
NDC Information of SORIATANE
| NDC Code | 0145-3817-03 |
| Proprietary Name | SORIATANE |
| Package Description | 30 CAPSULE in 1 BOTTLE (0145-3817-03) |
| Product NDC | 0145-3817 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acitretin |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100104 |
| Marketing Category Name | NDA |
| Labeler Name | Stiefel Laboratories Inc |
| Substance Name | ACITRETIN |
| Strength Number | 17.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
